Clinical trial
Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers
NCT00039975 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00039975 |
|---|---|
| Title | Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers |
| Official title | Evaluation of Potential Pharmacokinetic Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, Cardiovascular Diseases, Hypertension |
| Intervention type | Drug |
| Interventions | Indinavir sulfate, Ritonavir, Amlodipine, Diltiazem HCl |
| Enrollment | 32 |
| Completion | Apr 1, 2004 |
| First posted | Jun 20, 2002 |
| Last update posted | Nov 1, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: